TCR analysis43 also revealed a significant decrease in clonotype diversity of tumor-associated, but not in spleen-associated, CD8+ T cells upon BAY-I treatment (Fig. 7F and Supplementary Figure 6). The gene discussed is CD8A; the disease is neoplasm.